Biotech tax credit faces demise amid talk of special session

ANNAPOLIS — A Rockville-based biotechnology company spent the last year trying to kill off bacteria that cause stomach ulcers, the kind of research that would be difficult to conduct without significant outside investment. But by passing a “doomsday” budget containing $500 million in spending cuts, the Maryland General Assembly could instead kill off Sequella Inc.’s research ...

Leave a Reply

Your email address will not be published. Required fields are marked *